Gene: ZFP30
Official Full Name: ZFP30 zinc finger proteinprovided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30309 | ZFP30 Knockout cell line (HeLa) | Human | ZFP30 | 1:3~1:6 | Negative | Online Inquiry |
KO30310 | ZFP30 Knockout cell line (HCT 116) | Human | ZFP30 | 1:2~1:4 | Negative | Online Inquiry |
KO30311 | ZFP30 Knockout cell line (HEK293) | Human | ZFP30 | 1:3~1:6 | Negative | Online Inquiry |
KO30312 | ZFP30 Knockout cell line (A549) | Human | ZFP30 | 1:3~1:4 | Negative | Online Inquiry |
ZFP30 Gene Knockout Cell Lines represent a pioneering advancement in genetic research tools, specifically designed to facilitate the investigation of ZFP30, a zinc finger protein involved in various biological processes such as cell development, signal transduction, and gene expression regulation. These cell lines are engineered through precise gene editing technologies, such as CRISPR-Cas9, to create knockout variants that lack functional ZFP30. This allows researchers to study the resultant phenotypic implications of ZFP30 deletion, providing insights into its role in cellular mechanisms and potential pathologies.
The key functions of these ZFP30 knockout cell lines allow for a deep dive into not only the gene's biological significance but also its interactions with different signaling pathways. When coupled with various assays, researchers can elucidate the consequences of ZFP30 gene absence on cell viability, proliferation, differentiation, and response to external stimuli, shedding light on its potential implications in developmental disorders and diseases.
Scientifically, the ZFP30 Gene Knockout Cell Lines hold substantial value in both basic and applied research, facilitating a deeper understanding of gene function implicated in gene regulatory networks. Their utilization extends into clinical research domains, including cancer biology and regenerative medicine, where elucidating gene function is crucial for therapeutic advancements.
Compared to other genetic manipulation techniques, such as conventional knockdown approaches, ZFP30 knockout cell lines provide a more definitive and lasting alteration of gene function, thus presenting an unrivaled opportunity for concise data collection and analysis. By offering a more refined model for studying ZFP30, these cell lines stand out as superior alternatives.
These cell lines not only empower researchers in unraveling the complexities of genetic regulation but also provide clinicians with a robust platform for exploring novel therapeutic targets. Our company, with extensive expertise in genetic engineering and a commitment to advancing biomedical research, is proud to offer this innovative product, enabling transformative breakthroughs in the understanding and application of gene regulation dynamics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.